Security key
874060205
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)
CUSIP: 874060205
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 68,069,757
- Total 13F value
- $1,063,701,562
- Share change
- +2,636,048
- Put/Call ratio
- 77%
- SEC-reported price per share
- $15.60
- Number of holders
- 278
- Value change
- +$48,470,698
- Number of buys
- 113
- Number of sells
- 139
Open additional details 1 more signal available
Report period
Q4 2022
Institutions
278
Top holders
10
TAK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
TAKEDA PHARMACEUTICAL CO LTD SEC filings
TAKEDA PHARMACEUTICAL CO LTD company facts
TAKEDA PHARMACEUTICAL CO LTD 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 874060205
Recent filing periods:
Ownership snapshot
Top reported holders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mondrian Investment Partn...
Disclosed value leader
Mondrian Investment Partn...
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F
Highest disclosed value: $61,772,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Mondrian Investment Partners LTD has the largest disclosed position value at $61.77M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mondrian Investment Partners LTD's linked filing trail.
Disclosed position value
Top 5
Mondrian Investment Partners LTD
$61.77M
MORGAN STANLEY
$59.96M
Clal Insurance Enterprises Holdin...
$56.3M
GOLDMAN SACHS GROUP INC
$55.41M
MACQUARIE GROUP LTD
$51.8M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mondrian Investment Partners LTD |
13F
Company
|
—
class O/S missing
|
$61,772,000
4,751,715 shares
|
— | 30 Sep 2022 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$59,961,000
4,623,007 shares
|
— | 30 Sep 2022 |
| Clal Insurance Enterprises Holdings Ltd |
13F
Company
|
—
class O/S missing
|
$56,296,000
4,340,500 shares
|
— | 30 Sep 2022 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
class O/S missing
|
$55,414,000
4,272,469 shares
|
— | 30 Sep 2022 |
| MACQUARIE GROUP LTD |
13F
Company
|
—
class O/S missing
|
$51,803,000
3,994,044 shares
|
— | 30 Sep 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
class O/S missing
|
$36,953,000
2,849,100 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
278
Shares
68,069,757
Rows available
278
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
258
Q4 2022 holders
278
Holder diff
20
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend